Regarding the association of p-EGFR expression with the prognosis of nasopharyngeal carcinoma patients, the pooled 95% CI crossed 1 for the outcome of OS and DMFS, suggesting no association of p-EGFR overexpression with OS or DMFS. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.